Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Robert Hershberg

Premium

Adaptive Biotechnologies has appointed Robert Hershberg to its board of directors. Hershberg is CEO, board member, and co-founder of VentiRx Pharamaceuticals, and he previously was senior vice president and chief medical officer at Dendreon, an assistant professor at Harvard Medical School, and an associate physician at Brigham and Women's Hospital.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.